Jelena Pavlovic
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jelena Pavlovic.
Headache | 2014
Jelena Pavlovic; Dawn C. Buse; C. Mark Sollars; Sheryl R. Haut; Richard B. Lipton
In this second of a 2‐part series, we review the available literature on trigger factors and premonitory features in migraine.
Headache | 2016
Vincent T. Martin; Jelena Pavlovic; Kristina M. Fanning; Dawn C. Buse; Michael L. Reed; Richard B. Lipton
To examine the relationship of headache frequency to the stages of the menopausal transition in mid‐life women with migraine.
Headache | 2014
Richard B. Lipton; Jelena Pavlovic; Sheryl R. Haut; Brian M. Grosberg; Dawn C. Buse
In this review, we focus on migraine as a chronic disorder with episodic attacks (CDEA). We aim to review methodological approaches to studying trigger factors and premonitory features that often precede a migraine attack.
Journal of Headache and Pain | 2015
Jelena Pavlovic; Walter F. Stewart; Christa Bruce; Jennifer A. Gorman; Haiyan Sun; Dawn C. Buse; Richard B. Lipton
BackgroundStudies of the difference between menstrually associated and non-menstrually associated migraine are somewhat controversial. The majority of studies have focused on comparing menstrual to non-menstrual attacks rather than comparing study groups with different migraine diagnoses with respect to menstruation. As there is limited knowledge available on the overall impact and burden of migraine among groups of women with and without menstrually associated migraine our goal was to examine differences between these groups. We hypothesized that there would be greater burden of migraine related to menstruation and headache frequency in a population study across groups of women.MethodsWe analyzed data from the American Migraine Prevalence and Prevention (AMPP) Study, a longitudinal, US, population-based study. We included female respondents to the 2009 survey, aged 18 to 60, who met modified ICHD-2 criteria for migraine, were actively menstruating and fit one of three definitions based on the self-reported association of menses and migraine attacks: self-reported predominantly menstrual migraine (MM, attacks that only or predominantly occur at the time of menses), self-reported menstrually-associated migraine (MAM, attacks commonly associated with menses, but that also occur at other times of the month), and self-reported menstrually-unrelated migraine (MUM). These three groups were compared on characteristics and measures of headache impact and burden (Headache Impact Test– 6 item (HIT-6) and Migraine Disability Assessment Scale (MIDAS).ResultsThere were 1,697 eligible subjects for this study in the following categories: MM (5.5%), MAM (53.8%), or MUM (40.7%). Women with MM had an older age of migraine onset. Those with predominantly menstrually-related attacks (MM) had fewer headache-days but appeared to be more impaired by attacks. HIT-6 and MIDAS scores were significantly higher for both the MM and MAM groups compared with the MUM groups; however, effects were more robust for MM than MAM.ConclusionsNearly 60% of women with migraine reported an association between migraine and menses. These women reported greater headache impact and migraine-related burden on functioning than those in whom migraines were not related to menstruation. Women with MM were more impaired by attacks while women with MAM had overall highest burden, likely due to experiencing migraines on additional days.
Neurology | 2016
Jelena Pavlovic; Amanda A. Allshouse; Nanette Santoro; Sybil L. Crawford; Rebecca C. Thurston; Genevieve Neal-Perry; Richard B. Lipton; Carol A. Derby
Objective: To compare daily sex hormone levels and rates of change between women with history of migraine and controls. Methods: History of migraine, daily headache diaries, and daily hormone data were collected in ovulatory cycles of pre- and early perimenopausal women in the Study of Womens Health Across the Nation. Peak hormone levels, average daily levels, and within-woman day-to-day rates of decline over the 5 days following each hormone peak were calculated in ovulatory cycles for conjugated urinary estrogens (E1c), pregnanediol-3-glucuronide, luteinizing hormone, and follicle-stimulating hormone. Comparisons were made between migraineurs and controls using 2-sample t tests on the log scale with results reported as geometric means. Results: The sample included 114 women with history of migraine and 223 controls. Analyses of within-woman rates of decline showed that E1c decline over the 2 days following the luteal peak was greater in migraineurs for both absolute rate of decline (33.8 [95% confidence interval 28.0–40.8] pg/mgCr vs 23.1 [95% confidence interval 20.1–26.6] pg/mgCr, p = 0.002) and percent change (40% vs 30%, p < 0.001). There was no significant difference between migraineurs and controls in absolute peak or daily E1c, pregnanediol-3-glucuronide, luteinizing hormone, and follicle-stimulating hormone levels. Secondary analyses demonstrated that, among migraineurs, the rate of E1c decline did not differ according to whether a headache occurred during the cycle studied. Conclusions: Migraineurs are characterized by faster late luteal phase E1c decline compared to controls. The timing and rate of estrogen withdrawal before menses may be a marker of neuroendocrine vulnerability in women with migraine.
Headache | 2015
Dale S. Bond; Dawn C. Buse; Richard B. Lipton; J. Graham Thomas; Lucille Rathier; Julie Roth; Jelena Pavlovic; E. Whitney Evans; Rena R. Wing
Obesity is related to migraine. Maladaptive pain coping strategies (eg, pain catastrophizing) may provide insight into this relationship. In women with migraine and obesity, we cross‐sectionally assessed: (1) prevalence of clinical catastrophizing; (2) characteristics of those with and without clinical catastrophizing; and (3) associations of catastrophizing with headache features.
Headache | 2014
Richard B. Lipton; Daniel Serrano; Jelena Pavlovic; Aubrey Manack; Michael L. Reed; Catherine C. Turkel; Dawn C. Buse
Refine the classification of migraine subtypes by applying factor mixture models (FMM) to a large population sample of people with headache.
Cephalalgia | 2016
Richard B. Lipton; Daniel Serrano; Dawn C. Buse; Jelena Pavlovic; Andrew Blumenfeld; David W. Dodick; Sheena K. Aurora; Werner J. Becker; Hans-Christoph Diener; Shuu-Jiun Wang; Maurice Borges Vincent; Nada Hindiyeh; Amaal J. Starling; Patrick Gillard; Sepideh F. Varon; Michael L. Reed
Background Migraine, particularly chronic migraine (CM), is underdiagnosed and undertreated worldwide. Our objective was to develop and validate a self-administered tool (ID-CM) to identify migraine and CM. Methods ID-CM was developed in four stages. (1) Expert clinicians suggested candidate items from existing instruments and experience (Delphi Panel method). (2) Candidate items were reviewed by people with CM during cognitive debriefing interviews. (3) Items were administered to a Web panel of people with severe headache to assess psychometric properties and refine ID-CM. (4) Classification accuracy was assessed using an ICHD-3β gold-standard clinician diagnosis. Results Stages 1 and 2 identified 20 items selected for psychometric validation in stage 3 (n = 1562). The 12 psychometrically robust items from stage 3 underwent validity testing in stage 4. A scoring algorithm applied to four symptom items (moderate/severe pain intensity, photophobia, phonophobia, nausea) accurately classified most migraine cases among 111 people (sensitivity = 83.5%, specificity = 88.5%). Augmenting this algorithm with eight items assessing headache frequency, disability, medication use, and planning disruption correctly classified most CM cases (sensitivity = 80.6%, specificity = 88.6%). Discussion ID-CM is a simple yet accurate tool that correctly classifies most individuals with migraine and CM. Further testing in other settings will also be valuable.
Journal of Neuroscience Research | 2017
Jelena Pavlovic; Didem Akcali; Hayrunnisa Bolay; Carolyn Bernstein; Nasim Maleki
Migraine is a common neurological disorder with significantly higher incidence and prevalence in women than men. The presentation of the disease in women is modulated by changes in sex hormones from adolescence to pregnancy and menopause. Yet, the effect of sex influences has often been neglected in both basic and clinical and in clinical management of the disease. In this review, evidence from epidemiological, clinical, animal, and neuroimaging studies on the significance of the sex‐related influences in migraine is presented, and the unmet needs in each area are discussed.
Headache | 2017
Elizabeth K. Seng; Dawn C. Buse; Jaclyn E. Klepper; Sarah Jo Mayson; Amy S. Grinberg; Brian M. Grosberg; Jelena Pavlovic; Matthew S. Robbins; Sarah Vollbracht; Richard B. Lipton
To evaluate the relationships among modifiable psychological factors and chronic migraine and severe migraine‐related disability in a clinic‐based sample of persons with migraine.